GHK-Cu 50mg+ TB-500 10mg+ BPC-157 10mg+ KPV 10mg
$120.00
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
GHK-Cu 50mg + TB-500 10mg+ BPC-157 10mg+ KPV 10mg. 80 MG total is an 80-milligram research blend that combines GHK-Cu (glycyl L histidyl L lysine copper complex) with TB-500 (a thymosin beta 4 fragment), BPC-157 (a 15 amino acid synthetic peptide derived from a gastric protective protein sequence), and KPV (a tripeptide fragment of alpha MSH). Because these peptides are frequently discussed together in exploratory research, the blend is primarily used where investigators want a single material for comparative or screening work across multiple peptide pathways.
GHK-Cu has been studied for its potential relevance to connective tissue and extracellular matrix regulation in cell and tissue models, while TB-500 and BPC-157 have been investigated in preclinical systems involving soft tissue, tendon and ligament models, and angiogenesis related signaling. KPV is of interest in research examining melanocortin linked pathways and cytokine signaling, including barrier function models. Work on GHK-Cu + TB-500 + BPC-157 + KPV 80MG typically focuses on hypothesis generation rather than established outcomes.
- Specification: 80MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
BPC-157 + GHK-GHK-Cu + TB-500 50MG is a 50-milligram combination format bringing together three widely studied research peptides used in preclinical recovery and tissue-model work. Researchers investigate BPC-157, a 15 amino acid peptide fragment, alongside the copper binding GHK tripeptide motif and TB-500, a thymosin beta 4 analogue fragment, in models involving connective tissue, angiogenesis signaling, and cellular migration pathways.
In Stock
Glutathione 1500MG is a 1500-milligram format of glutathione, a naturally occurring tripeptide made of glutamate, cysteine, and glycine. Researchers study glutathione in the context of cellular redox balance and antioxidant systems. It is also investigated in models involving detoxification pathways and oxidative stress biology.
In Stock
NAD 100MG is a 100-milligram format of nicotinamide adenine dinucleotide (NAD+), a ubiquitous pyridine nucleotide that participates in cellular redox reactions. Researchers study NAD+ in the context of mitochondrial metabolism, oxidative stress models, and enzyme systems such as sirtuins and PARPs.
In Stock
SS-31 50MG is a 50-milligram format of SS-31, a synthetic tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential to localize to mitochondria and for its use in preclinical models examining mitochondrial membrane and bioenergetic pathways.
In Stock
NAD 500MH refers to a 500MH format of nicotinamide adenine dinucleotide (NAD), a ubiquitous pyridine dinucleotide central to cellular redox chemistry. Researchers study NAD in work involving energy metabolism, mitochondrial function, and enzymatic pathways such as sirtuins and PARPs.
In Stock
MOTS-C 10MG is a 10-milligram format of MOTS-C, a 16 amino acid mitochondria-derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-C in relation to metabolic signaling, cellular stress responses, and mitochondrial nuclear communication in preclinical systems. Its small size and endogenous origin make it a common target in mechanistic peptide research.
In Stock
BPC-157 + TB-500 – 10MG combines two widely discussed research peptides in a single 10 mg format. BPC-157 is a synthetic 15 amino acid peptide derived from a gastric protective protein fragment, while TB-500 refers to a thymosin beta 4 fragment commonly studied in peptide research. Researchers investigate this pairing in preclinical work involving connective tissue pathways, angiogenesis related signaling, and models of tissue repair and recovery.
In Stock
CJC-1295 No DAC + Ipamorelin 10MG is a combined 10MG format pairing a CJC 1295 (no DAC) GHRH analogue with ipamorelin, a ghrelin receptor agonist peptide. This blend is commonly used in research that examines pulsatile growth hormone signaling pathways and IGF 1 related biomarkers. Studies have explored these peptides in endocrine and metabolism focused experimental models.
In Stock
Trestolone Acetate (Ment) 50mg ml 10ml is a specified format of trestolone acetate, a synthetic 19 nor androgen and anabolic steroid ester. Researchers study MENT in endocrinology and androgen receptor focused models, including comparisons to testosterone derived compounds. Work has also examined trestolone in the context of gonadotropin regulation and progestogenic activity using preclinical and in vitro methods.
In Stock
BPC-157 + TB-500 – 20MG combines two synthetic research peptides commonly discussed in preclinical recovery and tissue repair literature. BPC-157 is a 15 amino acid peptide originally derived from a gastric protective protein fragment, while TB-500 is a thymosin beta 4 related peptide fragment studied in models of cell migration and cytoskeletal dynamics. Researchers study this pairing in exploratory work involving connective tissue, angiogenesis signaling, and soft tissue research pathways.
In Stock
GHK-Cu 50MG is a 50-milligram format of copper peptide GHK-Cu, a coordination complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to Cu2+. Researchers study GHK-Cu in models involving skin biology, extracellular matrix signaling, and wound related pathways.
In Stock
CJC-1295 Without DAC 5MG | GHRH Peptide Analogue is a 5 milligram format of a synthetic growth hormone releasing hormone analogue commonly referenced as MOD GRF 1-29. Researchers study this short GHRH fragment for its potential to model pulsatile GH signaling and IGF 1 related pathways in preclinical and laboratory settings.
In Stock
